Andre Desormeaux

Title: Andre Desormeaux: Innovator in Targeted Pharmaceutical Formulations

Introduction

Andre Desormeaux is a notable inventor based in Neufchatel, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of targeted treatments for infectious diseases. With a total of three patents to his name, Desormeaux's work is characterized by innovative approaches to combating pathogens.

Latest Patents

One of Desormeaux's latest patents is focused on methods and formulations for targeting infectious agents that bear host cell proteins. This formulation is designed for the treatment of diseases caused by infectious agents that acquire host membrane proteins during their life cycle. The targeting pharmaceutical composition includes a ligand capable of binding to host membrane proteins, coupled with a lipid-comprising vesicle. This vesicle may or may not contain a drug effective in treating the disease. Specific liposomes bearing anti-HLA-DR or anti-CD4 antibodies, which may include antiviral drugs such as anti-HIV medications, are disclosed and claimed. Additionally, the patent outlines a method of formulation and a method for using this formulation in disease treatment.

Career Highlights

Throughout his career, Desormeaux has worked with various organizations, including Infectio Recherche Inc. His innovative work has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of infectious disease treatment.

Collaborations

Desormeaux has collaborated with notable individuals in his field, including Michel G. Bergeron and Michel J. Tremblay. These collaborations have further enhanced his research and development efforts.

Conclusion

Andre Desormeaux's contributions to targeted pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patents reflect a deep understanding of infectious diseases and the potential for effective treatments.